US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Seaport Therapeutics

24.08

-0.2300-0.95%

Post-market: 24.080.00000.00%16:10 EDT

Volume:110.49K

Turnover:2.68M

Market Cap:1.29B

PE:-9.57

High:26.47

Open:24.40

Low:23.46

Close:24.31

52wk High:26.47

52wk Low:14.85

Shares:53.53M

Float Shares:14.16M

Volume Ratio:0.88

T/O Rate:0.78%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5160

EPS(LYR):-10.0430

ROE:-28.08%

ROA:-18.90%

PB:3.05

PE(LYR):-2.40

Loading ...

Overview Company News Filings

Seaport Therapeutics Price Target Maintained with a $50.00/Share by HC Wainwright & Co.

Seaport Therapeutics Price Target Maintained with a $50.00/Share by HC Wainwright & Co.

Earnings Flash (SPTX) Seaport Therapeutics Posts Q2 Loss $1.78 a Share

MT Newswires Live

Seaport Therapeutics Q2 EPS $(1.78) Misses $(0.65) Estimate

Benzinga Earnings

Seaport Therapeutics Q2 FY26 Net Loss Widens to $62.6 Million; R&D Expenses Rise to $24.62 Million

Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

THOMSON REUTERS

Seaport Therapeutics Initiated at Buy by HC Wainwright & Co.

Seaport Therapeutics, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $50

THOMSON REUTERS

Seaport Therapeutics participates in a conference call with JPMorgan

Top Insider Just Boosted Stake in Seaport Therapeutics With a Bold Buy

Seaport Therapeutics Director Robert J. Hombach Trust Buys 13,000 Shares Worth $235,768

Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX)

Seaport Therapeutics Q1 Net Loss Widens

MT Newswires Live

Seaport Therapeutics Q1 EPS $(10.34) Misses $(9.48) Estimate

Benzinga Earnings

Seaport Therapeutics reports Q1 EPS ($10.34) vs. ($5.65) last year

Seaport Therapeutics sees cash runway into 2029

Earnings Flash (SPTX) Seaport Therapeutics Posts Q1 Net Loss $10.34 a Share, vs. FactSet Est of $10.64 Loss

MT Newswires Live

Seaport Therapeutics - Q1 Net Loss per Share $10.34

THOMSON REUTERS

Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

THOMSON REUTERS

Seaport Therapeutics - Seven-Day Glyphago Dosing Achieves Therapeutic Agomelatine Exposures Without Liver Enzyme Elevations

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/SPTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPTX\",,,,,undefined,":{"symbol":"SPTX","market":"US","secType":"STK","nameCN":"Seaport Therapeutics","latestPrice":24.08,"timestamp":1787601600000,"preClose":24.31,"halted":0,"volume":110486,"hourTrading":{"tag":"盘后","latestPrice":24.08,"preClose":24.08,"latestTime":"16:10 EDT","volume":1218,"amount":29329.44,"timestamp":1787602205400,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.00946112710818595,"floatShares":14160000,"shares":53530550,"eps":-2.516,"marketStatus":"Post-Mkt","change":-0.23,"latestTime":"08-24 16:16:58 EDT","open":24.4,"high":26.47,"low":23.46,"amount":2677328,"amplitude":0.123817,"askPrice":29.5,"askSize":100,"bidPrice":23.65,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-2.516,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"listingDate":1777608000000,"exchange":"NASDAQ","adjPreClose":24.31,"postHourTrading":{"tag":"盘后","latestPrice":24.08,"preClose":24.08,"latestTime":"16:10 EDT","volume":1218,"amount":29329.44,"timestamp":1787602205400,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.877544},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPTX\",,,,,undefined,":{"symbol":"SPTX","floatShares":14160000,"roa":"-18.90%","roe":"-28.08%","lyrEps":-10.043037,"volumeRatio":0.877544,"shares":53530550,"dividePrice":0,"high":26.47,"amplitude":0.123817,"preClose":24.31,"low":23.46,"week52Low":14.85,"pbRate":"3.05","week52High":26.47,"institutionHeld":0,"latestPrice":24.08,"committee":-0.980198,"eps":-2.516,"divideRate":0,"volume":110486,"delay":0,"ttmEps":-2.516,"open":24.4,"prevYearClose":18,"prevWeekClose":24.31,"prevMonthClose":20.46,"prevQuarterClose":21.72,"fiveDayClose":24.4,"twentyDayClose":20.54,"sixtyDayClose":18.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-03","symbol":"SPTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.71,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785729600000,"reportTimeType":"pre","actualEps":-1.78}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.3333,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":6,"updateTime":1785988800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SPTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SPTX","date":"2026-08-21","current":-9.636328,"percent":0.933333,"low":-14.505892,"twenty":-12.881452,"median":-12.180373,"eighty":-11.146457,"high":-9.149163,"avg":-11.977703,"sd":1.221174,"marketCap":1286606769},"quantilePoints":[{"date":"2026-05-08","current":-10.976498,"twenty":-12.440976,"median":-11.330579,"eighty":-11.259763,"marketCap":821931163},{"date":"2026-05-15","current":-11.99625,"twenty":-12.004748,"median":-11.348283,"eighty":-11.231436,"marketCap":898291219},{"date":"2026-05-22","current":-12.173291,"twenty":-12.004748,"median":-11.330579,"eighty":-11.135126,"marketCap":911548174},{"date":"2026-05-29","current":-13.31343,"twenty":-12.537286,"median":-11.684659,"eighty":-11.163453,"marketCap":996922959},{"date":"2026-06-05","current":-12.661922,"twenty":-12.698746,"median":-12.017495,"eighty":-11.247016,"marketCap":948137367},{"date":"2026-06-12","current":-12.548616,"twenty":-12.593938,"median":-12.03874,"eighty":-11.316416,"marketCap":939652917},{"date":"2026-06-18","current":-10.501726,"twenty":-12.6166,"median":-12.03874,"eighty":-11.222938,"marketCap":915372405},{"date":"2026-06-26","current":-11.889673,"twenty":-12.53162,"median":-11.895161,"eighty":-11.165224,"marketCap":1036351448},{"date":"2026-07-02","current":-13.173217,"twenty":-12.752567,"median":-12.017495,"eighty":-11.198861,"marketCap":1148230297},{"date":"2026-07-10","current":-12.595929,"twenty":-12.752567,"median":-12.03874,"eighty":-11.215593,"marketCap":1097911580},{"date":"2026-07-17","current":-11.987935,"twenty":-12.752567,"median":-12.12726,"eighty":-11.302253,"marketCap":1044916336},{"date":"2026-07-24","current":-13.474144,"twenty":-12.866109,"median":-12.187454,"eighty":-11.330579,"marketCap":1174460267},{"date":"2026-07-31","current":-12.479243,"twenty":-12.804736,"median":-12.201617,"eighty":-11.330579,"marketCap":1087740776},{"date":"2026-08-07","current":-14.1804,"twenty":-12.896856,"median":-12.347233,"eighty":-11.365987,"marketCap":1236020399},{"date":"2026-08-14","current":-9.423399,"twenty":-12.896856,"median":-12.221306,"eighty":-11.295171,"marketCap":1269209340},{"date":"2026-08-21","current":-9.552568,"twenty":-12.881452,"median":-12.180373,"eighty":-11.146457,"marketCap":1286606769}],"updateTime":1787598021349},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660834682","title":"Seaport Therapeutics Price Target Maintained with a $50.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2660834682","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660834682?lang=en_us&edition=fundamental","pubTime":"2026-08-20 18:17","pubTimestamp":1787221020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SPTX/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656373765","title":"Seaport Therapeutics Price Target Maintained with a $50.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2656373765","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656373765?lang=en_us&edition=fundamental","pubTime":"2026-08-04 18:36","pubTimestamp":1785839760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SPTX/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656783373","title":"Earnings Flash (SPTX) Seaport Therapeutics Posts Q2 Loss $1.78 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2656783373","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656783373?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:11","pubTimestamp":1785755472,"startTime":"0","endTime":"0","summary":"Earnings Flash (SPTX) Seaport Therapeutics Posts Q2 Loss $1.78 a Share","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656337346","title":"Seaport Therapeutics Q2 EPS $(1.78) Misses $(0.65) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2656337346","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656337346?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:05","pubTimestamp":1785755116,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics (NASDAQ:SPTX) reported quarterly losses of $(1.78) per share which missed the analyst consensus estimate of $(0.65) by 173.85 percent. This is a 72.19 percent increase over losses of $(6.40) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60867629/seaport-therapeutics-q2-eps-1-78-misses-0-65-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656571373","title":"Seaport Therapeutics Q2 FY26 Net Loss Widens to $62.6 Million; R&D Expenses Rise to $24.62 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656571373","media":"Reuters","labels":["executive","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656571373?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:00","pubTimestamp":1785754842,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics Q2 FY26 net loss widens to $62.6 million; R&D expenses rise to $24.62 millionSeaport Therapeutics posted a Q2 2026 net loss of USD 62.6 million, widening from USD 15.1 million a y","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL3pblhQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656543373","title":"Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2656543373","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656543373?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:00","pubTimestamp":1785754801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nTUA33FR3M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651345211","title":"Seaport Therapeutics Initiated at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2651345211","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651345211?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:51","pubTimestamp":1784112660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SPTX/analyst-ratings(END) Dow Jones NewswiresJuly 15, 2026 06:51 ET","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651451223","title":"Seaport Therapeutics, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2651451223","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651451223?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:04","pubTimestamp":1784109841,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nAZN4T7XXX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651648525","title":"Seaport Therapeutics participates in a conference call with JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2651648525","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651648525?lang=en_us&edition=fundamental","pubTime":"2026-07-15 02:50","pubTimestamp":1784055022,"startTime":"0","endTime":"0","summary":"JPMorgan holds a conference call with management on July 14 at 3 pm. Webcast Link Published first on TheFly – the ultimate source for real-time, ma...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-participates-in-a-conference-call-with-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-participates-in-a-conference-call-with-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPTX","LU0310799852.SGD","LU1548497426.USD","LU2430703095.HKD","LU1988902786.USD","LU0211328371.USD","IE00B1BXHZ80.USD","SG9999002224.SGD","IE00BYXW3230.USD","LU2357627491.SGD","LU1551013425.SGD","LU2211815571.USD","LU0859254822.USD","LU2236285917.USD","IE00BJTD4N35.SGD","LU2552382058.USD","VFH","LU0149725797.USD","LU1363072403.SGD","LU2237443622.USD","LU2106854487.HKD","FNCL","IE0034235188.USD","IYG","LU2242649171.HKD","LU1496350171.SGD","LU2054465674.USD","JPMO","LU1116320737.USD","PGF","LU1670628061.USD","BK4516","LU0417517546.SGD","IXG","LU1116320901.HKD","LU0234572021.USD","LU1720051108.HKD","LU2505996681.GBP","IE00BN8TJ469.HKD","KBWB","LU2381873111.SGD","JPM","IYF","XLF","JPX","LU0238689110.USD","JPO","FTXO","UYG","IE00B775SV38.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646823822","title":"Top Insider Just Boosted Stake in Seaport Therapeutics With a Bold Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2646823822","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646823822?lang=en_us&edition=fundamental","pubTime":"2026-06-25 10:04","pubTimestamp":1782353050,"startTime":"0","endTime":"0","summary":"New insider activity at Seaport Therapeutics, Inc. ( ($SPTX) ) has taken place on June 24, 2026. Director Robert Hombach has increased his stake in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-insider-just-boosted-stake-in-seaport-therapeutics-with-a-bold-buy-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-insider-just-boosted-stake-in-seaport-therapeutics-with-a-bold-buy-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645463891","title":"Seaport Therapeutics Director Robert J. Hombach Trust Buys 13,000 Shares Worth $235,768","url":"https://stock-news.laohu8.com/highlight/detail?id=2645463891","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645463891?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:05","pubTimestamp":1782295548,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics director Robert J. Hombach trust buys 13,000 shares worth $235,768Seaport Therapeutics director Robert J. Hombach reported an indirect purchase of 13,000 common shares.The shares ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL752g0n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Seaport Therapeutics Director Robert J. Hombach Trust Buys 13,000 Shares Worth $235,768","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642249886","title":"Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642249886","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642249886?lang=en_us&edition=fundamental","pubTime":"2026-06-09 21:01","pubTimestamp":1781010094,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Alamar Biosciences, Inc. (ALMR) and Seaport Therapeutics, In...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-na-stocks-alamar-biosciences-inc-almr-seaport-therapeutics-inc-sptx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-na-stocks-alamar-biosciences-inc-almr-seaport-therapeutics-inc-sptx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NA","ALMR","BK4007","BLSX","BLSG","BK4121","SPTX","BK4141","BLSH","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641194489","title":"Seaport Therapeutics Q1 Net Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2641194489","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641194489?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:32","pubTimestamp":1780918324,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics  reported Monday its Q1 net loss widened to $10.34 per diluted share, compared with a loss of $5.65 a year earlier.Two analysts polled by FactSet expected a loss of $10.64.Cash, cash equivalents, and investments totaled $212.6 million as of March 31, which along with its initial public offering proceeds are expected to fund operations into 2029, the company said. Seaport said it raised $260 million in gross proceeds from its IPO in May.Shares of Seaport were up 3.8% in premarket activity Monday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641489546","title":"Seaport Therapeutics Q1 EPS $(10.34) Misses $(9.48) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2641489546","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641489546?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:22","pubTimestamp":1780917762,"startTime":"0","endTime":"0","summary":"Seaport Therapeutics (NASDAQ:SPTX) reported quarterly losses of $(10.34) per share which missed the analyst consensus estimate of $(9.48) by 9.07 percent.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/06/53053637/seaport-therapeutics-q1-eps-10-34-misses-9-48-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641374489","title":"Seaport Therapeutics reports Q1 EPS ($10.34) vs. ($5.65) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2641374489","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641374489?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:18","pubTimestamp":1780917532,"startTime":"0","endTime":"0","summary":"“The first quarter of 2026 was filled with meaningful progress for Seaport, and we significantly advanced the clinical development of our lead Glyp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-reports-q1-eps-10-34-vs-5-65-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-reports-q1-eps-10-34-vs-5-65-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641489568","title":"Seaport Therapeutics sees cash runway into 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2641489568","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641489568?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:17","pubTimestamp":1780917470,"startTime":"0","endTime":"0","summary":"Cash, cash equivalents, and investments totaled $212.6 million as of March 31, 2026. Subsequent to March 31, 2026, Seaport completed its IPO, in wh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-sees-cash-runway-into-2029-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seaport-therapeutics-sees-cash-runway-into-2029-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IPOS","SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641486206","title":"Earnings Flash (SPTX) Seaport Therapeutics Posts Q1 Net Loss $10.34 a Share, vs. FactSet Est of $10.64 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486206","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641486206?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:09","pubTimestamp":1780916971,"startTime":"0","endTime":"0","summary":"Earnings Flash (SPTX) Seaport Therapeutics Posts Q1 Net Loss $10.34 a Share, vs. FactSet Est of $10.64 Loss","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641864744","title":"Seaport Therapeutics - Q1 Net Loss per Share $10.34","url":"https://stock-news.laohu8.com/highlight/detail?id=2641864744","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641864744?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:05","pubTimestamp":1780916700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA2FRLJF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641861724","title":"Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2641861724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641861724?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:05","pubTimestamp":1780916700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA2FRLJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641609486","title":"Seaport Therapeutics - Seven-Day Glyphago Dosing Achieves Therapeutic Agomelatine Exposures Without Liver Enzyme Elevations","url":"https://stock-news.laohu8.com/highlight/detail?id=2641609486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641609486?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA7QNNCD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SPTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}]}}